Procedure for Stability Testing of Biologics in Compliance with Biosimilar Regulations

1) Purpose

The purpose of this SOP is to define the procedures for conducting stability testing of biologics under biosimilar regulatory guidelines. This ensures that biosimilar products meet the required standards of quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of biologics, including quality control, product development, and regulatory affairs teams.

3) Responsibilities

Biologics Development Team: Responsible for developing the biologic formulation and selecting suitable packaging.
Stability Study Team: Responsible for conducting stability studies in compliance with biosimilar guidelines.
Regulatory Affairs Team: Responsible for ensuring data submission complies with biosimilar regulations.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that aligns with biosimilar regulatory guidelines.

4.1.2 Include test parameters such as potency, purity, degradation products, and immunogenicity.

4.2 Sample Preparation and Storage

4.2.1

Prepare samples from representative batches in their final packaging.

4.2.2 Store samples under specified conditions (e.g., refrigerated, frozen) as per guidelines.

4.3 Conducting Stability Tests

4.3.1 Conduct tests at defined intervals to evaluate product stability over time.

4.3.2 Document all data and ensure adherence to protocol requirements.

4.4 Data Analysis and Reporting

4.4.1 Analyze data to determine any